This is an old revision of this page, as edited by Beetstra (talk | contribs) at 15:58, 10 January 2012 (Saving copy of the {{drugbox}} taken from revid 456953721 of page Vinorelbine for the Chem/Drugbox validation project (updated: 'DrugBank', 'ChEMBL').). The present address (URL) is a permanent link to this revision, which may differ significantly from the current revision.
Revision as of 15:58, 10 January 2012 by Beetstra (talk | contribs) (Saving copy of the {{drugbox}} taken from revid 456953721 of page Vinorelbine for the Chem/Drugbox validation project (updated: 'DrugBank', 'ChEMBL').)(diff) ← Previous revision | Latest revision (diff) | Newer revision → (diff)This page contains a copy of the infobox ({{drugbox}}) taken from revid 456953721 of page Vinorelbine with values updated to verified values. |
Clinical data | |
---|---|
Trade names | Navelbine |
AHFS/Drugs.com | Monograph |
MedlinePlus | a695013 |
Pregnancy category |
|
Routes of administration | intravenous, oral |
ATC code | |
Legal status | |
Legal status | |
Pharmacokinetic data | |
Bioavailability | 43 ± 14% (oral) |
Protein binding | 79 to 91% |
Metabolism | Hepatic (CYP3A4-mediated) |
Elimination half-life | 27.7 to 43.6 hours |
Excretion | Fecal (46%) and renal (18%) |
Identifiers | |
IUPAC name
| |
CAS Number | |
PubChem CID | |
DrugBank | |
ChemSpider | |
UNII | |
KEGG | |
Chemical and physical data | |
Formula | C45H54N4O8 |
Molar mass | 778.932 g/mol g·mol |
3D model (JSmol) | |
SMILES
| |
InChI
| |
(what is this?) (verify) |
- Marty M, Fumoleau P, Adenis A, Rousseau Y, Merrouche Y, Robinet G, Senac I, Puozzo C (2001). "Oral vinorelbine pharmacokinetics and absolute bioavailability study in patients with solid tumors". Ann Oncol. 12 (11): 1643–9. doi:10.1023/A:1013180903805. PMID 11822766.
{{cite journal}}
: CS1 maint: multiple names: authors list (link)